See your results below for :
Fulphila 0.6ML of 6MG/0.6ML : Syringe - 1

Fulphila Coupons & Prices

What is Fulphila ?

Fulphila (pegfilgrastim-jmdb) is a biosimilar to Neulasta (pegfilgrastim) used to help reduce the chance of infection due to a low white blood cell count in patients with non-myeloid cancer receiving myelosuppressive chemotherapy. It operates by stimulating the growth of white blood cells, specifically neutrophils, to help fight off infection. Administered via subcutaneous injection, Fulphila is typically given once per chemotherapy cycle, 24 hours after the administration of cytotoxic chemotherapy.

Name

Form

Dosage

Quantity

Consumer Forms
Injectable

Consumer Routes
By injection

Therapeutic Classes
Hematopoietic

Side Effects
Warnings

Pain, redness, or swelling where the shot was given
Bone, arm, or leg pain
Trouble breathing or fast breathing
Swelling in your face, ankles, or feet
Lightheadedness, dizziness, fainting
Skin redness, blisters, or sores, red or purple spots on your skin
Fever, chills, cough, sore throat, body aches, back or stomach pain
Decrease in how much or how often you urinate, red or dark brown urine, lower back or side pain
Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
Unusual bleeding, bruising, tiredness, or weakness
Pain in your left side or shoulder, or feeling unusually full

Unusual bleeding, bruising, tiredness, or weakness
Trouble breathing or fast breathing
Keep all medicine out of the reach of children. Never share your medicine with anyone.
Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results.
This medicine lowers the number of certain blood cells, so you may bleed or bruise more easily. Be careful to avoid injuries.
On-body Injector (OBI) for Neulasta®: Keep the injector at least 4 inches away from electrical equipment, including cell or cordless phones, microwaves, and other appliances.Do not use hot tubs or saunas while you are wearing the injector. Do not expose the injector to sunlight. Do not sleep on the injector. Call your doctor if the injector comes off before or during a dose.Keep the injector dry at least 3 hours before the dose is scheduled to start. This will help you notice any leaks. Call your doctor if the bandage becomes wet or the medicine is dripping.The injector is programmed to deliver your dose about 27 hours after it is placed on your skin. It will take about 45 minutes for the dose to be given. Avoid activities, including driving and traveling, that may interfere with the injector 1 hour before the dose starts, while it is being given, and for at least 1 hour afterward.You should avoid airport X-ray scans and request a manual pat down instead.You should avoid sleeping on the OBI for Neulasta® or applying pressure on the OBI for Neulasta®. Doing so may prevent the OBI from working properly.You should avoid getting body lotions, creams, oils, and cleaning agents near the OBI for Neulasta® as these products may loosen the adhesive that holds the OBI into your body.
This medicine may cause the following problems:Spleen problemsLung problems (including acute respiratory distress syndrome)Kidney problemsCapillary leak syndromeBlood or bone marrow problems (including myelodysplastic syndrome and acute myeloid leukemia) in patients with breast or lung cancerAortitis (inflammation of the aorta, the largest artery in the body)
Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, lung disease, breathing problems, or sickle cell disease. Tell your doctor if you have an allergy to acrylic adhesives or latex.